Current Opinion in Lipidology volume 18, issue 2, P164-173 2007 DOI: 10.1097/mol.0b013e3280555083 View full text
|
|
Share
Gerd Schmitz, Anna Schmitz-Mądry, Peter Ugocsai

Abstract: Statin therapy is widely used and well tolerated by the majority of patients. To further reduce potential adverse effects and to increase efficacy, combined therapy concepts with ezetimibe or niacin are underway.